Dipti Baskar, Rita Christopher, Gautham Arunachal, Davuluri Durga Srinivas Anudeep, Ambati Mounika, T A Sangeeth, Kiran Polavarapu, B S Shalini, Tarachand Joshi, Sai Bhargava Sanka, Saraswati Nashi, Pritam Raja, Ravindranadh Mundlamuri Chowdary, Ravi Yadav, Atchayaram Nalini, Seena Vengalil
{"title":"Acute myeloneuropathy due to Glutaric aciduria-1: Expanding the phenotypic spectrum.","authors":"Dipti Baskar, Rita Christopher, Gautham Arunachal, Davuluri Durga Srinivas Anudeep, Ambati Mounika, T A Sangeeth, Kiran Polavarapu, B S Shalini, Tarachand Joshi, Sai Bhargava Sanka, Saraswati Nashi, Pritam Raja, Ravindranadh Mundlamuri Chowdary, Ravi Yadav, Atchayaram Nalini, Seena Vengalil","doi":"10.1016/j.gmg.2025.100036","DOIUrl":null,"url":null,"abstract":"<p><p>Glutaric aciduria type-1 (GA-1) is a rare metabolic disorder due to mutation in <i>GCDH</i> gene resulting in varied clinical manifestations. Here we report a case of late-onset GA-1 with acute myelo-neuropathy and chronic renal failure. Institutional ethics committee approval was obtained and genetic analysis was done by clinical exome sequencing. Here we present 19 year-old-adolescent male with chronic renal disease for 2 years presented with 5 months history of sudden onset weakness of proximal and distal lower limbs and bladder retention. This was preceded by recurrent episodes of vomiting. On clinical examination he had features of myeloneuropathy. Laboratory evaluation showed significant elevation of blood glutaryl carnitine with very low free carnitine, while extensive white matter signal changes with diffusion restriction, subependymal nodules and involvement of internal capsule were evidenced on brain magnetic resonance imaging. Diagnosis was confirmed by clinical exome sequencing which showed a pathogenic homozygous missense mutation in exon 11 of <i>GCDH</i> gene (c .120 C>T, p.His403Tyr). This report expands phenotypic spectrum of GA-1 to include late onset acute myelo-neuropathy with chronic renal failure. A high index of suspicion is required since early treatment might decelerate further disease progression.</p>","PeriodicalId":40142,"journal":{"name":"Global Medical Genetics","volume":"12 2","pages":"100036"},"PeriodicalIF":1.5000,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11871448/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global Medical Genetics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.gmg.2025.100036","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0
Abstract
Glutaric aciduria type-1 (GA-1) is a rare metabolic disorder due to mutation in GCDH gene resulting in varied clinical manifestations. Here we report a case of late-onset GA-1 with acute myelo-neuropathy and chronic renal failure. Institutional ethics committee approval was obtained and genetic analysis was done by clinical exome sequencing. Here we present 19 year-old-adolescent male with chronic renal disease for 2 years presented with 5 months history of sudden onset weakness of proximal and distal lower limbs and bladder retention. This was preceded by recurrent episodes of vomiting. On clinical examination he had features of myeloneuropathy. Laboratory evaluation showed significant elevation of blood glutaryl carnitine with very low free carnitine, while extensive white matter signal changes with diffusion restriction, subependymal nodules and involvement of internal capsule were evidenced on brain magnetic resonance imaging. Diagnosis was confirmed by clinical exome sequencing which showed a pathogenic homozygous missense mutation in exon 11 of GCDH gene (c .120 C>T, p.His403Tyr). This report expands phenotypic spectrum of GA-1 to include late onset acute myelo-neuropathy with chronic renal failure. A high index of suspicion is required since early treatment might decelerate further disease progression.
戊二酸尿1型(GA-1)是一种罕见的由GCDH基因突变引起的代谢性疾病,临床表现多样。这里我们报告一例迟发性GA-1伴急性髓神经病变和慢性肾衰竭。获得机构伦理委员会批准,并通过临床外显子组测序进行遗传分析。我们报告一位19岁的青少年男性,患有慢性肾脏疾病2年,有5个月的突然发作的下肢近端和远端虚弱和膀胱潴留的病史。这之前是反复发作的呕吐。临床检查有髓神经病变的特征。实验室检查显示血戊二酰肉碱明显升高,游离肉碱极低,脑磁共振成像显示白质信号广泛改变,扩散受限,室管膜下结节及内囊受累。临床外显子组测序显示GCDH基因11外显子出现致病性纯合错义突变(c .120 c >T, p.His403Tyr)。本报告扩大了GA-1的表型谱,包括迟发性急性髓神经病变伴慢性肾衰竭。需要高度的怀疑指数,因为早期治疗可能会减缓疾病的进一步发展。